XML 57 R47.htm IDEA: XBRL DOCUMENT
v3.26.1

Research Grants (Details) - USD ($) $ in Thousands |  | 1 Months Ended | 3 Months Ended | 6 Months Ended |
--- | --- | --- | --- | --- | ---
Sep. 30, 2025 | Dec. 31, 2024 | May 31, 2023 | Mar. 31, 2023 | Jun. 30, 2026 | Jun. 30, 2025 | Jun. 30, 2026 | Jun. 30, 2025 | Dec. 31, 2025
Eurostars and Innosuisse |  |  |  |  |  |  |  |  |
Research Grants |  |  |  |  |  |  |  |  |
Amount of research grant awarded |  |  |  | $ 450 |  |  |  |  |
Unused portion of granted awards repaid | $ 210 |  |  |  |  |  |  |  |
Reduction of research and development expenses through expenses reimbursed |  |  |  |  | $ 2 | $ 309 | $ 16 | $ 503 |
Research grants receivables |  |  |  |  | 449 |  | 449 |  | $ 442
Innosuisse |  |  |  |  |  |  |  |  |
Research Grants |  |  |  |  |  |  |  |  |
Amount of research grant awarded |  |  | $ 2,800 |  |  |  |  |  |
Amount of research grant awarded, amended amount |  | $ 2,000 |  |  |  |  |  |  |
Australian Government |  |  |  |  |  |  |  |  |
Research Grants |  |  |  |  |  |  |  |  |
Reduction of research and development expenses through expenses reimbursed |  |  |  |  | $ 200 | $ 200 | $ 400 | $ 400 |
Consortium with GT Gain Therapeutics SA, Institute for Research in Biomedicine, Newcells Biotech and the University of Helsinki | Eurostars and Innosuisse |  |  |  |  |  |  |  |  |
Research Grants |  |  |  |  |  |  |  |  |
Amount of research grant awarded |  |  |  | $ 1,300 |  |  |  |  |

X
- Definition Amount of research grant awarded. + References No definition available. + Details
Name: | ganx_AmountOfResearchGrantAwarded
Namespace Prefix: | ganx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of research grant awarded, amended amount. + References No definition available. + Details
Name: | ganx_AmountOfResearchGrantAwardedAmendedAmount
Namespace Prefix: | ganx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The reduction of research and development expenses through expenses reimbursed + References No definition available. + Details
Name: | ganx_ReductionOfResearchAndDevelopmentExpensesThroughExpensesReimbursed
Namespace Prefix: | ganx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash outflow for the repayment of grants awarded. + References No definition available. + Details
Name: | ganx_RepaymentOfGrants
Namespace Prefix: | ganx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 5: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 8: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 9: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(3)(a)(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_GrantsReceivable
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | srt_CounterpartyNameAxis=ganx_EurostarsAndInnosuisseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=ganx_InnosuisseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=ganx_AustralianGovernmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=ganx_ConsortiumWithGtGainTherapeuticsSaInstituteForResearchInBiomedicineNewcellsBiotechAndUniversityOfHelsinkiMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |